Gamma Biomedical

Founded in 2014, Gamma Biomedical specialises in disrupting existing markets to provide easy, more affordable access to biomedical products. A multinational organisation, our goal is to improve access to products and services that wouldn’t ordinarily be available for Australian health care providers. Gamma Biomedical holds a variety of medical wholesale licenses that cover the broad gamut of scheduled medicines in Australia. We have extensive, multi-year, experience with international health regulations and logistics, ensuring legal compliance and smooth supply chains. We currently have three subsidiary brands specialising in immunotherapy and allergy (Gamma Allergy), and medicinal cannabis (Isospec CBD & Sol Cannabis). Currently providing prescription medications to tens of thousands of patients nation wide.